Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease

Clinical trial NCT07123350 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07123350
Sponsor: Vanderbilt University Medical Center
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Inflammatory Bowel Disease (IBD)Crohn&Amp;#39;s Disease (CD)Ulcerative Colitis (UC)

Start date: 2025-10-16
Primary completion: 2026-03-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.